These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
103 related articles for article (PubMed ID: 29238260)
21. The Effects of Inhaled Terbutaline on 3-km Running Time-Trial Performance. Molphy J; Dickinson JW; Chester NJ; Loosemore M; Whyte G Int J Sports Physiol Perform; 2019 Jul; 14(6):822–828. PubMed ID: 30569748 [TBL] [Abstract][Full Text] [Related]
22. Analysis of refractory period after exercise and eucapnic voluntary hyperventilation challenge. Rosenthal RR; Laube BL; Hood DB; Norman PS Am Rev Respir Dis; 1990 Feb; 141(2):368-72. PubMed ID: 2105684 [TBL] [Abstract][Full Text] [Related]
23. Comparable reductions in hyperpnoea-induced bronchoconstriction and markers of airway inflammation after supplementation with 6·2 and 3·1 g/d of long-chain n-3 PUFA in adults with asthma. Williams NC; Hunter KA; Shaw DE; Jackson KG; Sharpe GR; Johnson MA Br J Nutr; 2017 May; 117(10):1379-1389. PubMed ID: 28606216 [TBL] [Abstract][Full Text] [Related]
24. Refractory period during provocation with eucapnic hyperventilation and methacholine. Hurwitz KM; Roach JM; Argyros GJ; Eliasson AH; Phillips YY Am J Respir Crit Care Med; 1994 Jun; 149(6):1452-6. PubMed ID: 8004298 [TBL] [Abstract][Full Text] [Related]
25. Airway response to methacholine following eucapnic voluntary hyperpnea in athletes. Bougault V; Blouin E; Turmel J; Boulet LP PLoS One; 2015; 10(3):e0121781. PubMed ID: 25789614 [TBL] [Abstract][Full Text] [Related]
26. Inhaled beta-agonists improve lung function but not maximal exercise capacity in cystic fibrosis. Dodd JD; Barry SC; Daly LE; Gallagher CG J Cyst Fibros; 2005 May; 4(2):101-5. PubMed ID: 15978535 [TBL] [Abstract][Full Text] [Related]
27. The ergogenic effect of long-term use of high dose salbutamol. Dickinson J; Molphy J; Chester N; Loosemore M; Whyte G Clin J Sport Med; 2014 Nov; 24(6):474-81. PubMed ID: 24451697 [TBL] [Abstract][Full Text] [Related]
28. Clinical and functional responses to salbutamol inhaled via different devices in asthmatic patients with induced bronchoconstriction. Lavorini F; Geri P; Luperini M; Maluccio NM; Mariani L; Marmai C; Pistolesi M; Fontana GA Br J Clin Pharmacol; 2004 Nov; 58(5):512-20. PubMed ID: 15521899 [TBL] [Abstract][Full Text] [Related]
29. Exercise-induced bronchoconstriction diagnosis in asthmatic children: comparison of treadmill running and eucapnic voluntary hyperventilation challenges. Chateaubriand do Nascimento Silva Filho MJ; Gonçalves AV; Tavares Viana M; Peixoto DM; Cavalcanti Sarinho ES; Rizzo JÂ Ann Allergy Asthma Immunol; 2015 Oct; 115(4):277-81. PubMed ID: 26238422 [TBL] [Abstract][Full Text] [Related]
30. Hyperpnea-induced bronchoconstriction and urinary CC16 levels in athletes. Bolger C; Tufvesson E; Sue-Chu M; Devereux G; Ayres JG; Bjermer L; Kippelen P Med Sci Sports Exerc; 2011 Jul; 43(7):1207-13. PubMed ID: 21131866 [TBL] [Abstract][Full Text] [Related]
31. Impact of detecting and treating exercise-induced bronchoconstriction in elite footballers. Jackson AR; Hull JH; Hopker JG; Dickinson JW ERJ Open Res; 2018 Apr; 4(2):. PubMed ID: 29692994 [TBL] [Abstract][Full Text] [Related]
32. Exercise performance after salbutamol inhalation in non-asthmatic, non-athlete individuals: a randomised, controlled, cross-over trial. Eckerström F; Rex CE; Maagaard M; Rubak S; Hjortdal VE; Heiberg J BMJ Open Sport Exerc Med; 2018; 4(1):e000397. PubMed ID: 30233808 [TBL] [Abstract][Full Text] [Related]
33. Exercise capacity and exercise-induced bronchoconstriction (EIB) in a cold environment. Stensrud T; Berntsen S; Carlsen KH Respir Med; 2007 Jul; 101(7):1529-36. PubMed ID: 17317135 [TBL] [Abstract][Full Text] [Related]
34. Eucapnic voluntary hyperventilation is superior to methacholine challenge testing for detecting airway hyperreactivity in nonathletes. Holley AB; Cohee B; Walter RJ; Shah AA; King CS; Roop S J Asthma; 2012 Aug; 49(6):614-9. PubMed ID: 22793526 [TBL] [Abstract][Full Text] [Related]
35. Inhaled formoterol in the prevention of exercise-induced bronchoconstriction in asthmatic children. Boner AL; Spezia E; Piovesan P; Chiocca E; Maiocchi G Am J Respir Crit Care Med; 1994 Apr; 149(4 Pt 1):935-9. PubMed ID: 7908246 [TBL] [Abstract][Full Text] [Related]
36. Vitamin D and omega-3 polyunsaturated fatty acid supplementation in athletes with exercise-induced bronchoconstriction: a pilot study. Price OJ; Hull JH; Howatson G; Robson-Ansley P; Ansley L Expert Rev Respir Med; 2015 Jun; 9(3):369-78. PubMed ID: 25864870 [TBL] [Abstract][Full Text] [Related]
37. Long duration of airway but not systemic effects of inhaled formoterol in asthmatic patients. Lötvall J; Ankerst J Respir Med; 2008 Mar; 102(3):449-56. PubMed ID: 18023335 [TBL] [Abstract][Full Text] [Related]
38. A dose-ranging study of the bronchodilator effects of abediterol (LAS100977), a long-acting β2-adrenergic agonist, in asthma; a Phase II, randomized study. Singh D; Pujol H; Ribera A; Seoane B; Massana E; Astbury C; Ruiz S; de Miquel G BMC Pulm Med; 2014 Nov; 14():176. PubMed ID: 25398689 [TBL] [Abstract][Full Text] [Related]